Medicinal herbs in the United States: research needs. by Matthews, H B et al.
Cmrmrnw5Ptaries
Medicinal Herbs in the United States: Research Needs
Hazel B. Matthews,1 George W Lucier,1 and Kenneth D. Fisher2
'National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA; 2Office of Disease Prevention and
Health Promotion, Department of Health and Human Services, Washington, DC, USA
Virually all cultures have, throughout history, used avariety ofplants or materials derived from
plantsfortheprevention andtreatment ofdisease. Evidenceofthe beneficial therapeuticeffects of
these medial herbs is seen in their continued use. Additionally, the development of modern
chemistrypermitted the isolation ofchemnicals from medicinal herbs that have served as drugs or
starting materials for the synthesis of many important drugs used today. Many more modern
drugs have been synthesized as a result ofknowledge gained from studies ofmechanisms of
actions ofchemicals first isolated from medicinal herbs. Thus, medicinal herbs have played a
major role in the development ofmodern medicine and continue to bewidely used in their origi-
nal form. Whereas it is generally agreed that most medicinal herbs are safe under the conditions
used, some are toxic and should be avoided even though they are readily available, and others
have significant adverse side effectswhen misused. Also, little has beendoneto investigate poten-
tial adverse effects that may be associated with extended or high-dose use of medicinal herbs.
Thus, concern has been expressed thatthe lackofqualitycontrol used in thepreparation ofmedi-
cinal herbs, plus their unregulated sale and uninformed use, pose potential adverse health effects
for consumers. There is also concer regardingpotential herblherb orherbldrug interactions and
possible untoward healtheffects ofmedicinal herbs in sensitive subpopulations such as the young
and the elderly and certain genetically predisposed individuals. In this paper, we discuss these
concerns at some length and make recommendations for additional research and education dis-
cussed intherecentInternationalWorkshop to Evaluate Research Needs onthe UseandSafetyof
Medicinal Herbs. Key wordk; medicinal herbs, dietary supplements. Environ Health Perspect
107:773-778 (1999). [Online 25 August 1999]
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Much ofwhat is todayconsidered "alternative
medicine" in the more developed countries
was, in the not too distant past, theonlymed-
icine. Indeed, a major portion ofthe world's
population still depends almost exclusively on
what many in the more developed countries
consider alternative forms of treatment for
most health-related problems. In most cul-
tures, medicinal herbs have long constituted a
major component ofthese traditional or alter-
native treatments. Knowledge of the thera-
peutic properties ofplants predates recorded
history, and great respect was given to those
who possessed and passed on this knowledge
to succeeding generations. When consumed,
made into teas or infusions, or when applied
directly to an injury, certain plants appeared
to have almost magical healing properties.
Thus, among the treasures sought by early
explorers was knowledge ofthe existence and
use ofnew medicinal plants. These plants and
knowledge of their therapeutic uses were
returned to the home countries as part ofthe
justification ofearly explorations. Export of
medicinal plants back to the home countries
played a major role in disseminating both the
plants and knowledge of their medicinal
properties and helped to establish both early
trade between countries and the basis ofmod-
ern pharmaceuticals.
Knowledge gained from the use ofmedi-
cinal herbs and their active ingredients serves
as the foundation for much ofmodern phar-
macology. Drugs such as aspirin, digitalis,
morphine, and quinine were all originally
isolated orsynthesized from materials derived
from plants. Perhaps more important to the
development of pharmacology has been
knowledge gained from studies ofthe mecha-
nisms ofaction ofnaturally occurring chemi-
cals derived from medicinal plants. Studies of
chemicals derived from plants have support-
ed the development of new synthetic chemi-
cals that account for a major portion of the
drugs used in modern medicine. This fact is
well recognized by today's biomedical com-
munity that continues to send modern
explorers to the corners of the earth to find
newplant-related cures for our maladies.
The historic role of medicinal herbs in
the treatment and prevention of disease
and their role as catalysts in the development
of pharmacology do not, however, assure
their safety for uncontrolled use by an
uninformed public. Concern regarding the
current proliferation ofwidespread, uncon-
trolled, and largely uninformed or misin-
formed use of medicinal herbs was the
subject of a recent editorial in the New
EnglandJournalofMedicine (NEJM) (1) and
a series of articles in the Journal ofthe
American Medical Association (JAMA) (2).
The recent International Workshop to
Evaluate Research Needs on the Use and
Safety of Medicinal Herbs addressed the
need for additional research to support more
effective and safe use ofmedicinal herbs (3).
Use of Medicinal Herbs in the
United States
There is little question that many medicinal
herbs have preventive and/or therapeutic
effects. Thus, like any therapeutic agent,
when overdosed or incorrectly used, they also
have the potential to induce adverse effects.
The likelihood of adverse effects increases
when the production and sale ofsuch prod-
ucts is largely uncontrolled and the consumer
is not adequately informed as to their proper
uses. These concerns have been the major
focus ofthe recent articles (1,2) and thework-
shop mentioned above. In their editorial in
NEJM, Angell and Kassirer (1) discussed the
significance ofthe large and rapidly increasing
use of medicinal herbs in the United States.
They expressed concern for possible risks
associated with widespread use of prepara-
tions that have not been scientifically tested.
They also pointed out that, while most herbal
remedies are probably harmless, some may be
quite toxic, and the consumer is largely unin-
formed as to possible adverse effects. In his
guest editorial in JAMA, Wayne Jonas (4),
former Director of the National Institutes of
Health Office of Alternative Medicine,
endeavored to look at both sides ofthe issue
and stressed the fact that there are positive
and negative aspects of both alternative and
conventional medicine. He pointed out that
conventional medicine excels in the use ofsci-
entific methods to authenticate its benefits,
whereas alternative medicine depends largely
on anecdotal reports. He cautioned, however,
that the beneficial effects of medicinal herbs
may vary because of the lack ofstandardiza-
tion in collection and processing. Thus, while
acknowledging the beneficial effects of alter-
native medicine, Jonas (4) urged increased
research to confirm the beneficial and safe
uses and further research into the mechanisms
that account for the therapeutic effects of
alternative treatments. In the same issue of
JAMA, Fontanarosa and Lundberg (5) pointed
out that, although millions of patients use
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alternative practices such as medicinal herbs,
these practices have not been subjects ofprop-
erlydesigned andconducted randomized con-
trol trials. Thus, consumers are spending bil-
lions ofdollarsannually for remedies that may
or may not be effective and, in most cases, are
not reimbursed by insurance. Fontanarosa
and Lundberg (5) also pointed out that, in
some incidences, the alternative methods used
may, in fact, be contraindicated.
The use ofmedicinal herbs in the United
States, which was quite common in the nine-
teenth century and early in the twentieth
century, dedined with increased knowledge
of the germ theory of disease and the
increased availability ofsynthetic drugs. The
recent resurgence in the use of medicinal
herbs is speculated to be due to some disillu-
sionment with conventional medicine and its
increased costs plus changes in health care
delivery systems that make them more
impersonal. There has also been increased
interest in the use of"natural" alternatives in
the mistaken impression that natural prod-
ucts are always safe. Marketing and use of
these "natural" alternatives were greatly facili-
tated by the passage of the Dietary
Supplement Health and Education Act of
1994 (DSHEA) (6). The DSHEA included
medicinal herbs and other botanical products
in the definition of dietary supplements.
Thus, unless approved bythe Food and Drug
Administration (FDA), specific preventative
or therapeutic claims cannot be made for
medicinal herbs. Evidence of preventive
and/or therapeutic effects can, however, be
strongly inferred. (Medicinal herbs are more
widely used in many other developed coun-
tries, such as Germany, than in the United
States. They are frequently prescribed by
doctors, and their costs are often covered by
insurance. However, many of the products
that are readily available through a variety of
retail outlets in the United States are more
closely controlled and are available only by
prescription in manyEuropean countries.)
As a result ofincreased interest and pro-
motion and limited control, approximately
40% of the U.S. population is reported to
use some sort of dietary supplement.
Medicinal herbs now constitute the most
rapidly growing segment of the total U.S.
pharmaceutical market. According to the
Presidential Commission on Dietary
Supplement Labels, some 1,500-1,800
botanical products are sold in the United
States as dietary supplements or ethnic med-
icinals (7). These formulations are being
consumed by tens of millions of U.S. citi-
zens for both treatment and prevention ofa
wide variety of health-related problems.
Estimates ofthe market value ofherbal med-
icines in this country vary, but all sources
agree it is amultibillion dollar industry.
Concerns Regarding the Use
of Medicinal Herbs
A major portion of the world's population
depends almost exclusively on herbal prod-
ucts and other alternative methods as the
primary defense against or treatment for dis-
ease and various organic disorders. Further,
many botanical products continue to be used
today in a manner identical or very similar
to that used for thousands of years. This
long history of use lends credibility to sup-
port the beneficial effects of herbal medi-
cines in the prevention and treatment ofdis-
ease. However, although most botanical
products are probably safe under most con-
ditions, some are known to be toxic at high
doses and others may have potentially
adverse effects under some conditions. That
is, it must be assumed that ifthey have bene-
ficial therapeutic effects, the chemicals in
medicinal herbs, just as those in synthetic
drugs, also have the potential to cause
adverse effects. The intensity of adverse
effects would be expected to vary with dose,
responses of sensitive individuals based on
genetic predisposition, diet, drug interac-
tions, and other factors. Because medicinal
herbs are not prescribed by physicians or dis-
pensed by pharmacists, reports of their
adverse effects are largely anecdotal. Thus,
documentation of adverse effects associated
with the use of medicinal herbs is largely
limited to those reports associated with over-
dose and allergic reactions.
A number ofplants that have been or are
currently used as medicinal herbs are also
known to be ineffective or toxic and are not
recommended for use. The English transla-
tion of The Complete German Commission E
Monographs: Therapeutic Guide to Herbal
Medicines (8) lists more than 100 such inef-
fective or toxic herbs that have been used
medicinally but are no longer recommended.
Many are still available, however, and are
found in retail outlets along with safe and
effective medicinal herbs. There have been a
number of cases of injury and even death
resulting from misuse, contamination,
and/or adulteration of medicinal herbs (9).
Also, because they are not regulated for con-
tent or efficacy, it is not possible to know
how often medicinal herbs fail to contain the
advertised active ingredient and thus have no
effect. It is also impossible to determine
when a product might have contained sub-
stances that resulted in subtle adverse effects
that were not reported. Similarly, it is quite
possible that the placebo effect resulting
from widespread advertising, popular pro-
motion, and the natural tendency of most
common maladies to run their course
accounts for much of the beneficial effects
achieved with some products.
Other concernsregarding the use ofmed-
icinal herbs include the possibility of
herb/herb or herb/drug interactions and
allergic reactions (7-9). Any pharmacologi-
cally active agent has thepotential to result in
synergistic or antagonistic interaction when
consumed with other pharmacologically
active compounds. This is no less the case for
medicinal herbs. Medicinal herbs that have
similar or opposite therapeutic effects as
drugs or those that inhibit the metabolism of
drugs are the most likely candidates for
adverse interactions. Depending on the inter-
action involved, the action of a synthetic
drug may be enhanced or suppressed by co-
administration of an herb and vice versa.
Because interactions are not systematically
documented and such reports are largely
anecdotal, concern has been expressed
regarding potential interactions involving
prescription drugs. Warfarin, for example, is
administered to delay blood clot formation
and could be potentiated by co-administra-
tion of feverfew, garlic, ginkgo, ginger, or
ginseng, which have similar actions (10).
Taken together, warfarin and one or more of
these herbs might cause the patient to hem-
orrhage. St. John's wort, which is known to
enhance photosensitivity (11), should not be
used with other known photosensitizers (e.g.,
tetracycline). Additionally, St. John's wort is
known to inhibit monoamine oxidase and
may thus enhance the action of other
monoamine oxidase inhibitors or serotonin
reuptake inhibitors (1J). Valerian is not rec-
ommended for use with barbiturates because
it has been demonstrated to prolong barbitu-
rate-induced sleeping times (12). Concern
for the possibility ofadverse drug/herb reac-
tions is heightened by the fact that the poten-
tial for such interactions is not described on
the package inserts for most prescription
drugs, and herbal remedies do not require
package inserts. Thus, because the consumer
is uninformed and many patients do not
inform their physicians that they are also
using medicinal herbs, the potential for
adverse interaction is increased.
Recommendations for the use of pre-
scribed drugs (i.e., dose, manner, and fre-
quency ofadministration and the period for
which they are taken) are reviewed and con-
trolled by the prescribing physician. Because
they are usually self-prescribed by the con-
sumer, this is frequently not the case with
medicinal herbs. Further, the extended pre-
clinical and clinical testing to assure the safe-
ty of prescription drugs before they are
released to the market is not required for
medicinal herbs. Little is known about
chronic toxicities that might be associated
with their prolonged use. There has been
minimal research to address possible adverse
reproductive, immunologic, or neurologic
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effects or even systemic toxicity and/or
carcinogenicity that might be associated with
high doses or prolonged use of these prod-
ucts (10). This concern was frequently
expressed at the International Workshop to
Evaluate Research Needs on the Use and
Safety of Medicinal Herbs, where it was
strongly emphasized that medicinal herbs
cannot be assumed safe because they are
"natural" (3). Many natural products are
quite toxic or carcinogenic. For example,
strychnine (one ofthe most toxic chemicals
known), aflatoxin (which is both toxic and
carcinogenic), and pulegone (a toxic aborti-
facient) are all "natural" (8,9). Pulegone is
found in the medicinal herb pennyroyal,
which can be found in many outlets for
medicinal herbs. Medicinal herbs contain a
variety ofchemicals that are toxicwhen con-
sumed at high doses and for which little is
known about their chronic toxicity. Because
the DSHEA exempts dietary supplements
such as medicinal herbs from testing (6), the
public may be unknowingly exposed to
chemicals with the potential to induce avari-
ety of toxicities and/or carcinogenicity on
chronic use. Further, because such testing is
expensive and is not required, it is unlikely
to be performed by the producers or distrib-
utors ofthese products. This does not mean
that the industry is not interested in the safe-
ty of their products. Rather, as best
described by Loren Israelson (3), a
spokesperson for the herbal industry, there is
a financial disincentive for the industry to
support such research. Because these prod-
ucts cannot be patented, funding research
into their chronic effects would not confer
any proprietary right to the company that
supported the work. Thus, research funded
by one company could be used equally well
bytheircompetitors.
Other concerns regarding the marketing
and use ofmedicinal herbs voiced both in the
literature and at the recent workshop are
those ofstandardization and stability (1-3).
Unlike pharmaceuticals, botanical products
are complex mixtures in which the active
ingredients maynotbe known ormayconsti-
tute only a small percent ofthe total product.
Some products are, in fact, believed to
achieve their beneficial effects through the
combined actions ofseveral ingredient chem-
icals, each ofwhich accounts for a very small
portion ofthe total product. Quality control
issues are further complicated by the manner
in which these products are produced. That
is, unlike synthetic drugs that are produced
in highly purified form, medicinal herbs are
gathered in the wild or grown in relatively
small plots. Thus, the active ingredients may
vary significantly with the part of the plant
used, the season in which they are harvested,
and/or the growing conditions (e.g., weather,
soil, etc.). When these facts are combined
with the fact that these dried plant parts are
purchased locally by dealers who sell them to
the larger distributor, who in turn may fur-
ther market or formulate and distribute the
final product, the potential for misidentifica-
tion or cross contamination is apparent.
Because little is done to monitor the concen-
tration ofactive ingredients or the possibility
ofcross contamination through these steps,
the content of active ingredients in a given
product may vary significantly from one lot
to another.
As described by Joe Betz at the recent
International Workshop to Evaluate
Research Needs on the Use and Safety of
Medicinal Herbs, sophisticated analytical
procedures have and are being developed in
this country and elsewhere to analyze the
contents ofmedicinal herbs. Quality control
guidelines based on methods described in
pharmacopoeias from more than a dozen
nations have been described in a recent docu-
ment prepared by the World Health
Organization (WXHO) (13). A recent effort
by the U.S. Pharmacopeia has provided more
detailed methods for the standardization of
specific medicinal herbs and dietary supple-
ments (14). Monographs for the specific
herbs addressed are being published as they
are developed. These methods are only rec-
ommended, however, and are not required
foranyofthe products addressed.
As mentioned above, the active ingredi-
ents ofherbal formulations usually constitute
a small fraction ofthe total product. In some
cases, the active ingredient(s) are unknown or
only partially characterized. In other cases,
beneficial effects are attributed to a combina-
tion ofactive ingredients. Because thestability
of chemicals varies according to individual
structures of the chemicals and the formula-
tion in which they are found, the stability of
active ingredients ofmedicinal herbs is also a
matter ofconcern. However, the active ingre-
dients ofmanymedicinal herbs are unknown,
and for others our knowledge ofactive ingre-
dients is incomplete. Thus, expiration dates,
when present formedicinal herbs, may not be
meaningful. Because there has been relatively
little research to establish the active ingredi-
ent(s) of most medicinal herbs or to docu-
ment their shelflife, the efficacy ofa particu-
lar preparation may vary significantly with
time or from one brand to another. For those
preparations in which the active ingredients
are known, methods are available or could be
relatively easily developed to determine their
shelflife. However, this work is not required
and is not being widely employed to assure
products ofconsistent content andquality.
Representatives of the herbal industry
who attended the International Workshop
on Evaluating Research Needs on the Use
and Safety of Medicinal Herbs agreed that
the industry must provide safe products and
that current approaches for standardization
are inadequate (3). They emphasized that the
more responsible members of the industry
are working to improve and standardize their
products. There is general recognition, how-
ever, that some members ofthis diverse and
fragmented industry are marketing over the
Internet, through direct sales catalogs, and
even in service stations. This lack ofindustry
regulation permitted under the DSHEA
allows marketing of products of both ques-
tionable quality and content by individuals
whose financial interests may, in some cases,
override their interest in the safety and effica-
cy of their product. Descriptions of these
products outlandishly infer everything from
increased virility and vitality to a state of
ecstasy. In some cases, all three conditions
and more are promised if one consumes a
single pill that is claimed to contain a half-
dozen or more herbal products.
The ease of marketing dietary supple-
ments and the lack of regulatory control of
such marketing are illustrated by an article
published in the Wall StreetJournal (15). In
this case, an individual who was interested in
starting a business did so bysimply obtaining
a source ofdietary supplements and market-
ing over the Internet. His initial product was
the testosterone precursor androstenedione
that he had formulated into tablets and then
marketed as "The Stud Pill for Men." This
individual's research for the efficacy and safe-
ty ofthis product was limited to a cursory lit-
erature search and no laboratory work. No
approval or control by regulatory agencies
was necessary. His success ($30,000 gross in
the first month) was such that this individual
is now selling a weaker formulation of
androstenedine for women as the "Passion
Pill for Women" and a formulation of
ephedra, found in the herbal product Ma
Huang, as "HerbalTrim." Again, research
was limited to a briefreview ofthe literature.
The literature clearly states that profound
toxicity and a number of deaths have been
attributed to the use of ephedra or Ma
Huang, and a number ofadverse effects have
been reported for testosterone precursors.
These facts apparently did not deterhis profit
motive. This example ofeffective marketing,
in the absence of regulatory control, is pro-
jected to result in $500,000 gross sales of
these products by this individual in his first
year in business (15).
As a result of the actions of those who
are willing to take advantage ofthe freedom
to market dietary supplements permitted by
the DSHEA, the more responsible members
of the dietary supplement industry run the
risk that consumers might lose confidence
in reputable products. Consumers could be
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injured by the unscrupulous sale of misfor-
mulated or adulterated products. Under the
DSHEA there is little that can be done to
regulate such uncontrolled and possibly
even unscrupulous marketing. However,
recent guidelines from the Federal Trade
Commission (16) requiring truthfulness and
accuracy in advertising of these products
may curtail some of the more outlandish
claims currently being made.
Workshop speakers suggested that better
standardization and quality control may be
positive aspects of the recent entry of the
major pharmaceutical companies into the
medicinal herb market. Mass marketing by
the major pharmaceutical companies is also
likely to place economic pressure on sup-
pliers who do not have the resources to
maintain the good-manufacturing practices
necessary to assure quality control and stan-
dardized products.
A downside ofthe entrance ofthe major
pharmaceutical companies into the medicinal
herb market is that many people who would
not have otherwise used medicinal herbs will
be encouraged to use products that have not
been proven effective in normal healthy indi-
viduals. Increased self-medication also increas-
es the chance of adverse reactions to these
products as well as adverse drug/herb or
herb/herb interactions. The end result will be
millions ofdollars spent and not compensated
byinsurance forlitde or no beneficial effect.
A final concern regarding the use of
medicinal herbs is that ofrisks posed to sen-
sitive subpopulations. As discussed above,
the fact that medicinal herbs are natural does
not make them safe. The chemicals in medi-
cinal herbs may be formed naturally in the
plant, but they are not natural to the human
body. Any compound with a therapeutic
effect has the potential to be incorrectly pre-
scribed or overdosed. Increased sensitivity of
subpopulations is most frequently attributed
to slower metabolism of the compound
administered or to an allergic response.
Thus, it follows that individuals such as the
developing fetus, young children, and the
elderly, who are more sensitive to the effects
of pharmaceuticals, will also be at greater
risk to adverse health effects associated with
medicinal herbs. Additional sensitive indi-
viduals are seen among those genetic sub-
populations that metabolize foreign com-
pounds less rapidly than the general popula-
tion. Members of each of these various
groups may be harmed by what is for most
ofthe population the recommended dose of
a drug or herb. Sensitive subpopulations are
also at greater risk of adverse herb/drug or
herb/herb interactions.
Allergic reactions are not readily predict-
ed and may occur in response to any of a
large number of agents including synthetic
and natural drugs. Allergic responses to syn-
thetic drugs are frequently detected in the
course of preclinical testing, and this infor-
mation is provided to the patient and physi-
cian. Additional information is obtained on
synthetic drugs when patients are monitored
by the prescribing physicians and dispensing
pharmacists. Adverse responses and allergic
reactions are noted and reported to the
pharmaceutical companies who have the
responsibility to include this information in
the package insert for the respective drug.
Consumers are thus informed and fore-
warned of the possibility of adverse reac-
tions and are more likely to recognize these
reactions when they occur. Because medici-
nal herbs are not subject to similar testing
and monitoring and they usually do not
contain package inserts, the consumer may
be unaware that a decline in his or her
health is actually an adverse or hypersensi-
tive response to the herbal medication.
Problem Areas,
Recommendations,
and Actions
Standardization
Numerous speakers and participants at the
recent International Workshop to Evaluate
Research Needs on the Use and Safety of
Medicinal Herbs emphasized that herbal
medicines are poorly defined mixtures in
which the active principal has frequently not
been identified. Analysis of available medici-
nal herb preparations indicate that both the
ingredients, active and otherwise, may vary
greatly from one preparation to another. The
lackofstandardization is illustrated by an arti-
cle in Consumer Reports (17) that described
the analysis of 10 preparations ofginseng for
content ofthe possible active ingredients, gin-
senosides. The analysis indicated that the con-
tents ofginseng per capsule, when measured
by weight, varied by more than 6-fold, and
the ginsenosides per capsule varied by more
than 20-fold. Further, the content ofginseno-
sides did not necessarily vary in proportion to
the weight ofginseng in the capsule. In addi-
tion to better standardization ofthe products,
work is needed to confirm the stability ofthe
active ingredient(s) ofmedicinal herbs. In the
absence ofadequate standardization and qual-
ity control, both consumers and responsible
producers of medicinal herbs are at risk.
Consumers must have a consistent product of
high quality to effectively achieve safe, benefi-
cial effects from one formulation to another.
Responsible producers are at riskwhen incon-
sistent or ineffective products damage the rep-
utation ofthe industry.
Recommendations. Where methods for
such quality assurance are available, they
should be employed industry wide. When
such methods are lacking, research should be
undertaken by both the industry and govern-
ment to identify, certify, and quantify active
ingredients and to determine and recom-
mend optimum doses ofmedicinal herbs.
Formulations of medicinal herbs should
be standardized, to the extent possible, to
deliver a known amount ofthe active ingre-
dient(s) in a recommended dose. Where they
are known, the stability ofthe active ingredi-
ents should be determined, and all packages
should carry meaningful expiration dates.
Package inserts that contain dear instruc-
tions regardingdoses and possible contraindi-
cations should be prepared and required for
medicinal herbs.
Action. As discussed earlier, 'WHO (13)
has developedbasicmethods fortheanalysisof
medicinal herbs, and the U.S. Pharmacopeia
(14) is developing and publishing recom-
mended methods for specific herbal formula-
tions. As described by Joe Betz and William
R. Obermeyer at the workshop, research at
the FDA is currently addressing the need for
improved methods to ensure the content and
quality of medicinal herbs. Jill Ellis of the
National Nutritional Foods Association and
Loren Israelsen, of the Utah Natural
Products Alliance, two representatives of the
medicinal herb industry in attendance at the
workshop, emphasized that many compo-
nents of the industry are working to better
standardize their products. The entry of the
major pharmaceutical houses into the medic-
inal herb market is speculated to result in
more consistent formulations.
Consumer Education
The American public, overall, comprises a
well-educated and sophisticated group of
consumers. However, any consumer group
must base buying decisions on available
information. In the case ofmedicinal herbs,
information about health benefits has been
largely limited to that provided by a relative-
ly few advocates of their use and marketers
of these products. Thus, most of the avail-
able information has been limited to the
positive aspects associated with the use of
medicinal herbs, with little, if any, discus-
sion ofpossible adverse effects. The general
public is largely unaware that adverse health
effects associated with the use of medicinal
herbs have been attributed to everything
from overdosing to contaminated formula-
tions to the inherent toxicity ofthe herb of
choice. The public is also largely unaware
that much of the literature regarding the
beneficial effects of these compounds is
anecdotal, may be greatly exaggerated or
incorrect, and has yet to be confirmed
through clinical trials. Most of the clinical
trials that have been conducted have been
conducted in other countries, and in most
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cases, the results have not been translated
into English or evaluated by U.S. regulatory
officials. Thus, when it comes to medicinal
herbs, the American public may not be well-
educated consumers.
Recommendations. Because these prod-
ucts are not proprietary but are being con-
sumed by a large segment ofthe public, fed-
eral funds should be used to develop, evalu-
ate, and distribute the most authoritative
information available regarding the efficacy
andsafety ofherbal formulations.
Research conducted in other countries
should be translated and evaluated by federal
regulatory agencies. The most accurate data
regarding both beneficial and adverse effects
should be used to prepare informative pack-
age inserts to be included with all formula-
tions of medicinal herbs. Package inserts
should be updated as additional information
becomes available.
Action. The National Institutes ofHealth
(NIH) Office ofDietary Supplements (ODS)
was established by the DSHEA (6). The pur-
poses ofthe ODS were defined in the lawand
includethefollowing:
to more fully explore the potential role ofdietary
supplements as a significant component ofefforts
to improve health care, and to promote the sci-
entific study ofdietary supplements in maintain-
ing health and preventing chronic diseases and
other health-related conditions.
Working with representatives ofthe scientif-
ic community, consumers, and industry, the
ODS has developed a Strategic Plan that
includes five equallyweighed goals and relat-
ed objectives (18). The Strategic Plan goals
include the following:
* Evaluate the role ofdietary supplements in
the prevention ofdisease and reduction of
riskfactors associatedwith disease
* Evaluate the role ofdietary supplements in
physical and mental health and in perfor-
mance
* Explore the biochemical and cellular effects
of dietary supplements on biological sys-
tems and their physiological impact across
the life cycle
* Improve scientific methodology as related
to thestudyofdietarysupplements
* Inform and educate scientists, health care
providers, and the public about the bene-
fits and risks ofdietarysupplements.
Additional information on ODS efforts to
support research, improve education, and
disseminate knowledge is available on the
ODS web site (19).
An excellent source of information
regarding the use and safety of medicinal
herbs has recently been translated from
German into English (8). This text, translat-
ed by the American Botanical Council, pro-
vides awealth ofinformation on a multitude
of herbal formulations. The Botanical Safety
Handbook (11), another recently published
resource that contains a great deal ofvaluable
information, includes a listing of herbs by
Latin binomial, based in part on toxicologic
considerations and profiles of commonly
used herbal medicines. A third useful refer-
ence is the Physicians Desk Reference (PDR)
for Herbal Medicines (20). This publication
presents a comprehensive listing ofmedicinal
herbal products. Each entry provides infor-
mation and data on source, identity, formu-
lation, dosages, contraindications, and drug
interactions where known. The entries also
include references to published studies.
Information on benefits and risks associated
with the use of herbal supplements has
recently been made available on the Internet
from the FDA through the Center for Food
Safety and Applied Nutrition's dietary sup-
plements web site (21) and through the
NIH's National Center for Complementary
andAlternative Medicine (22).
Not all consumers have access to these
relatively expensive books or to the Internet.
Further, information for all supplements is
not available or may be incomplete. Thus,
when it is available, information regarding
recommended uses, doses, and possible con-
traindications would be most assessable if
required on a package insert with the respec-
tive product.
Herb/Drug and Herb/Herb
Interactions
Several speakers and discussants at the
International Workshop to Evaluate
Research Needs on the Use and Safety of
Medicinal Herbs expressed concern regard-
ing the simultaneous use of more than one
herbal product and/or the use of herbal
products in combination with pharmaceuti-
cals and/or alcohol. Documented incidences
of adverse effects, some leading to death,
were recounted by discussants at the work-
shop. Most ofthese incidences were associat-
ed with abuse. However, unrestrained mar-
keting and fraudulent advertising set the
stage for such adverse interactions. Patients
frequently do not inform their physicians
that they are also using herbal remedies.
Thus, when a physician prescribes a drug
having the same or an opposite pharmaco-
logic action, there is potential for adverse
interaction. In other cases these products
may be marketed as a combination ofherbal
compounds to be used as a means ofobtain-
ing extra energy, virility, or other desired
state and thus set the stage for abuse and
adverse interactions when combined with
illicit drugs and alcohol.
Recommendation. An initiative is needed
in the medical community and among the
producers and marketers of medicinal herbs
to identify and document herb/drug and
herb/herb interactions. Information obtained
from this initiative should be provided to
both the herbal and pharmaceutical indus-
tries and required on package inserts with the
respective products.
Action. A number of health care profes-
sionals who have treated patients experienc-
ing adverse interactions have endeavored to
bring this information to the attention ofthe
public. However, these efforts are as yet gain-
ing little attention from regulatory agencies
or the industry (11).
Potential ToxicityAssociated with
High Dose or Prolonged Use
Prescription drugs come with carefully writ-
ten instructions regarding their use and possi-
ble contraindications. The time over which
these products are used is limited by the expi-
ration of the prescription, and prescriptions
are not renewedwithout the recommendation
of a physician. Over-the-counter drugs are
not available until extended use has proved
them safe at the recommended dose, but
medicinal herbs, most ofwhich have not been
tested in clinical trials, are readily available to
a largely uninformed public. Little is known
regarding the potential ofthese compounds to
increase the risk of immunotoxicity, neuro-
toxicity, birth defects, reproductive problems,
orcancerwith extended use.
Recommendations. Because medicinal
herbs are not without therapeutic effect,
they, like other pharmaceuticals, will be
toxic at some dose. Medicinal herbs should
thus be tested to characterize both their
acute and chronic toxicities.
Action. In a continuing effort to address
those compounds to which the public is
exposed, the National Toxicology Program is
currently designing and initiating studies to
identify and characterize adverse effects that
may be associated with prolonged or high
doses ofsome ofthe more popular medicinal
herbs. Results of these studies will be peer
reviewed and made available as soon as they
arecompleted.
Sensitive Subpopulations
It has long been known that the developing
fetus, theyoung, and the elderly maybe more
sensitive to the effects of certain drugs than
the general population. There is also increas-
ing evidence for other sensitive subpopula-
tions as a result of genetic predisposition. In
most instances, sensitive subpopulations show
an elevated or adverse response as a result of
compromised capacity to metabolize the
respective drug. Also, individuals of all ages
may have allergic reactions to botanical prod-
ucts. Because medicinal herbs are therapeu-
tically active and metabolized in manners
similar to synthetic drugs, similar adverse
reactions to medicinal herbs can be expected
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in sensitive subpopulations. However, such
adverse reactions and allergic responses have
not been well documented, and information
regarding possible adverse responses is not
usually provided to the consumer. In some
cases, the public has actually been misled
when medicinal herbs have been marketed as
safe to all ages because theyare natural.
Recommendation. Research and data col-
lected from consumers should be compiled
and analyzed to identify sensitive subpopula-
tions based on age, sex, nutritional habits,
allergic responses, and the presence ofspecific
genes that may predispose consumers to an
elevated or toxic response to medicinal herbs.
Action. Little is being done to address
the needs ofsensitive subpopulations at this
time or to publicize the fact that they may be
at risk. Once comprehensive studies to char-
acterize the pharmacologic effects ofindivid-
ual agents are completed, it will be possible
to design better studies to address this issue.
Summary
Medicinal herbs are some ofour oldest med-
icines. The fact that theycontinue to be used
by millions of people is testament to both
their real and perceived beneficial effects.
Their increasing use in recent years is clear
evidence ofpublic interest in having alterna-
tives to conventional medicine. However,
the fact that medicinal herbs are "natural"
does not assure their safety. They have not
been tested in the manner required for con-
ventional pharmaceuticals. Thus, there is
limited data to confirm their efficacy and
little or no scientific data regarding possible
adverse effects associated with high doses or
chronic use or the hyperresponsiveness of
sensitive subpopulations. There is also con-
siderable concern regarding the lack ofstan-
dardization of herbal preparations and the
inadequacy ofconsumer information. Much
needed testing for safety and efficacy cannot
be mandated under the present laws regulat-
ing the industry. Given the economic disin-
centive for significant expenditures for such
research, the industry is unlikely to conduct
this research. Many of the concerns regard-
ing standardization and consumer informa-
tion could be addressed through reassess-
ment ofthe DSHEA. However, iftesting of
medicinal herbs for efficacy and safety is to
be conducted, it will probably have to be
supported by the government. Results of
testing, assessment ofdata from other coun-
tries, and documentation of adverse effects
resulting from interactions and hypersensi-
tive responses should provide information to
consumers in the form of package inserts
with all products.
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